Lung cancer study uses blood cells to guide future treatments
NCT ID NCT02630615
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study looks at circulating tumor cells (CTCs) in the blood of people with advanced lung cancer. The goal is to learn about DNA repair problems in these cells and test new drugs in the lab. About 80 participants will give blood samples to help researchers understand how to personalize treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Roudebush VA Medical Center
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.